Delivery Order SPE2DB24D1201-SPE2DB25FJBEA
Award Date
1/15/25
Potential Completion Date
1/16/25
Potential Value
$1.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with ID SPE2DB20D3111|SPE2DB25FA6BX, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which is a Delivery Order with a Firm Fixed Price pricing type, is for the supply of NOVOLOG 100 UNIT/ML VIAL 10ML, a medical product. The contract has a ceiling value of $2,159.49 and an ultimate completion date of January 3, 2025. The contract is not set aside for...
This federal contract award SPE2DB22D1106|SPE2DB25FDSP8, with a ceiling value of $1,234.85, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NOVOLOG 100 UNIT/ML VIAL 10ML, a pharmaceutical product. This is a delivery order contract with a firm fixed price pricing type, with a period of performance through January 3, 2025. The contract does not have a set-aside...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the supply of NOVOLOG 100 UNIT/ML VIAL 10ML, a type of medication. The award has a ceiling value of $1,944.90 and a period of performance through February 27, 2025. This appears to be a delivery order contract, with a firm fixed-price pricing type. The contract was not designated with a set-aside requirement, indicating open competition....
This federal contract award, valued at $6,280.63, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NOVOLOG 100 UNIT/ML VIAL 10ML, a pharmaceutical product, with a completion date of January 30, 2025. This award is a delivery order contract with a firm fixed price pricing type. The contract does not have a set-aside designation, indicating open competition....
This federal contract award, with ID SPE2DB22D1103|SPE2DB25FTDS4, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $3,305.89 firm fixed-price delivery order is for the supply of 4566831514 NOVOLOG 100 UNIT/ML VIAL 10ML pharmaceutical products. The contract has an ultimate completion date of January 6, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in...
This federal contract award, issued by the Defense Logistics Agency (DLA), was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,589.59, is a Delivery Order contract with a Firm Fixed Price pricing type. The award covers the procurement of NOVOLOG 100 UNIT/ML VIAL 10ML medical supplies, with an ultimate completion date of February 28, 2025. Amerisourcebergen Drug Corp is the prime contractor for this award and...
This federal contract award, with ID SPE2DB22D3010|SPE2DB25FP1KG, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of NOVOLOG 100 UNIT/ML VIAL 10ML, a pharmaceutical product, with a ceiling value of $12,686.07. The contract type is a Delivery Order with a Firm Fixed Price pricing type. The award has an ultimate completion date of January 17, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical...
This federal contract award, valued at $1,640.82, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of NOVOLOG 100 UNIT/ML VIAL 10ML, a medical product used for healthcare purposes. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of January 22, 2025. The contract does not have a set-aside designation,...
This federal contract award with ID SPE2DB24D1104|SPE2DB25FXWH9 was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp for the delivery of NOVOLOG 100 UNIT/ML VIAL 10ML medical supplies. The contract has a total ceiling value of $1,706.55 and runs through January 10, 2025. It is a Firm Fixed Price Delivery Order contract with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor...
This federal contract award, valued at $1,255.74, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp. The contract is a Delivery Order for the supply of NOVOLOG 100 UNIT/ML VIAL 10ML, a pharmaceutical product, to support military healthcare programs. The contract has a Firm Fixed Price pricing type and an ultimate completion date of January 6, 2025. The award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a major pharmaceutical...